LNSR — LENSAR, Inc.

LENSAR Q1 2026 Earnings Call Summary

1. Key Financial Results and Metrics

• Total Revenue: $13.4 million, down 5% from $14.2 million in Q1 2025.
• System Revenue: Approximately $800,000, significantly lower than $2.6 million in the prior year, attributed to reduced system placements.
• Recurring Revenue: Increased by 9% to $12.6 million, representing 94% of total revenue.
• Gross Margin: 48% of revenue, down from 50% year-over-year.
• Operating Expenses: Totaled $4.1 million, a significant decrease from $12.9 million in Q1 2025, largely due to a $4.4 million credit from acquisition costs.
• Net Income: $36.3 million or $1.56 per share, compared to a net loss of $27.3 million a year ago, influenced by noncash items.
• Adjusted EBITDA: Negative $311,000, down from positive $165,000 in Q1 2025.
• Cash Position: Ended the quarter with $13.5 million in cash and equivalents.

2. Strategic Updates and Business Highlights

• LENSAR has exited a merger-related holding pattern, allowing it to focus on independent growth and expansion.
• The company placed 7 ALLY systems during the quarter, bringing the total installed base to approximately 205 systems, with 11 more in backlog.
• Procedure volume increased to about 54,000, up from 52,000 in Q1 2025, with a U.S. market share of 23.4%.
• Strong interest in ALLY was noted at industry events, with over 50 system demonstrations conducted.
• The company is optimistic about rebuilding its international presence and expanding its installed base.

3. Forward Guidance and Outlook

• Management expects continued growth in recurring revenue as the installed base expands and utilization rates improve.
• The next few quarters are anticipated to show steady progress in rebuilding momentum, particularly in system placements.
• While specific guidance was not provided, there is optimism regarding a rebound in growth rates, especially looking towards 2027.

4. Bad News, Challenges, or Points of Concern

• The decline in system revenue reflects ongoing challenges in placement activity, particularly due to the prior merger uncertainty.
• The international market has seen limited contributions over the past year, impacting overall growth.
• Operating expenses are expected to rise as LENSAR rebuilds its workforce to support growth.
• Competitive pressures remain, particularly from older systems like Alcon's LenSx, which may delay decision-making among potential customers.

5. Notable Q&A Insights

• Management confirmed that recent purchase orders from distributors indicate a positive trend in rebuilding relationships and sales.
• There is a cautious approach to increasing operating expenses, with plans to rebuild the team judiciously.
• The company emphasized the importance of the recurring revenue model, which is expected to support growth even during slower system placement periods.
• There is confidence in the ability to convert users of older systems, with a focus on the efficiency and benefits of the ALLY system compared to competitors.

Overall, LENSAR is positioned for recovery and growth following a challenging period, with a strong emphasis on enhancing its technology and expanding its market presence.